enGene Holdings Inc.
ENGN · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| R&D Expenses | $32 | $23 | $20 | $20 |
| G&A Expenses | $8 | $7 | $7 | $6 |
| SG&A Expenses | $8 | $7 | $7 | $6 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $1 |
| Operating Expenses | $39 | $30 | $27 | $27 |
| Operating Income | -$39 | $30 | $27 | -$27 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1 | -$1 | -$2 | $2 |
| Pre-Tax Income | -$38 | $29 | $26 | -$25 |
| Tax Expense | -$0 | $0 | $0 | $0 |
| Net Income | -$38 | -$29 | $26 | -$25 |
| % Margin | – | – | – | – |
| EPS | -0.74 | -0.57 | 0.51 | -0.48 |
| % Growth | -29.8% | -211.8% | 206.3% | – |
| EPS Diluted | -0.74 | -0.57 | 0.51 | -0.48 |
| Weighted Avg Shares Out | 51 | 51 | 51 | 51 |
| Weighted Avg Shares Out Dil | 51 | 51 | 51 | 51 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $2 | $2 | $3 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$37 | -$28 | -$25 | -$24 |
| % Margin | – | – | – | – |